MSI Financial Services’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

MSI Financial Services’s Portfolio INFI Stock Details INFI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-1,350	Closed	-$7K	–	4134
2016 Q1	$7K	Hold	1,350	–	–	﹤0.01%	3007
2015 Q4	$11K	Buy	+1,350	New	+$11.6K	﹤0.01%	2675
2015 Q1	–	Sell	-118	Closed	-$2K	–	3165
2014 Q4	$2K	Hold	118	–	–	﹤0.01%	2439
2014 Q3	$2K	Hold	118	–	–	﹤0.01%	2438
2014 Q2	$2K	Buy	+118	New	+$1.23K	﹤0.01%	2387

Other funds holding INFI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

MSI Financial Services's INFI Position: Q2 2016 in Review

MSI Financial Services sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q2 2016, closing a stake of 1,350 shares — an estimated $7K sold.

MSI Financial Services first reported a position in INFI in Q2 2014 and held it in 5 quarters. The position peaked at $11K in Q4 2015. 107 funds tracked by Wall St. Rank hold INFI as of Q2 2016.

MSI Financial Services reported no remaining Infinity Pharmaceuticals, Inc. position as of Q2 2016 after selling out during the quarter.
MSI Financial Services sold 1,350 Infinity Pharmaceuticals, Inc. shares in Q2 2016, an estimated $7K.
MSI Financial Services first reported a position in Infinity Pharmaceuticals, Inc. in Q2 2014 and held it in 5 quarters.
MSI Financial Services's Infinity Pharmaceuticals, Inc. position peaked at $11K in Q4 2015.
107 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q2 2016.

Based on MSI Financial Services's 13F filing for Q2 2016, filed 25 Jul 2016.